Welcome to our dedicated page for James Hardie Industries plc SEC filings (Ticker: JHIUF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on James Hardie Industries plc's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into James Hardie Industries plc's regulatory disclosures and financial reporting.
James Hardie Industries plc (JHX) reported insider equity transactions by Jonathan Skelly, President of James Hardie NA. On 2026-08-25 he exercised 50,000 employee stock options with an exercise price of $11.23 per share, which had been assumed in connection with the acquisition of The AZEK Company Inc. and were exercisable as of July 1, 2025. He then sold a total of 65,000 ordinary shares in open-market transactions at weighted average prices of approximately $30.45 and $30.46 per share, including 50,000 shares sold through a broker-assisted cashless exercise. Following the derivative transaction, he held 287,721 employee stock options directly.
James Hardie Industries plc (JHX) is the issuer for which officer Jonathan Skelly has filed a notice of proposed sale of up to 65,000 shares of common stock under Rule 144. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $1,979,094.56 as of the notice date. The 65,000 shares consist of 15,000 shares acquired in a merger on 07/02/2025 and 50,000 shares acquired through a stock option exercise on 08/25/2026, both from the issuer. Shares outstanding were 580,522,488 as of 08/25/2026; this is a baseline figure, not the amount being sold.
James Hardie Industries plc (JHX) director Jesse G. Singh reported multiple option exercises and related share sales. On August 21 and 24, 2026, he exercised in total 530,100 employee stock options at an exercise price of $11.23 per share, receiving the same number of ordinary shares. The filing shows aggregate sales of 871,557 ordinary shares at weighted-average prices around $30 per share, including broker-assisted cashless exercises and sales by trusts for which Singh or his spouse serve as trustee or grantor-trustee.
James Hardie Industries plc (symbol JHX) received a notice that director Jesse Singh, through Goldman Sachs & Co. LLC as broker, plans to sell up to 120,000 shares of common stock under Rule 144, with an aggregate market value of $3,624,000, on or about August 24, 2026 on the NYSE. These shares were acquired from the issuer on July 2, 2025 as compensation in the form of restricted stock units. The notice also reports two prior sales on August 21, 2026 of 118,057 shares for $3,578,233.88 and 103,400 shares for $3,121,085.32.
James Hardie Industries plc (JHX) received a notice under Rule 144 for proposed sales of its common stock by director Jesse G. Singh. The notice lists a planned sale related to a stock option exercise involving 265,100 shares of common stock, with a proposed sale date of 08/24/2026. It also reports that during the past three months, Singh sold 265,000 common shares for aggregate proceeds of 8,001,542.50 on 08/21/2026. Fidelity Brokerage Services LLC signed the notice as attorney-in-fact for Singh.
James Hardie Industries plc (JHX) reported an equity compensation grant to CEO and director Aaron M. Erter. On 2026-08-20, he received 60,588 ordinary shares in the form of restricted stock units that vest in three equal annual installments beginning on June 15, 2027, subject to continued service. On the same date he was also granted 75,495 non-qualified stock options with a $25.17 exercise price, expiring on 2036-08-20 and vesting in three equal annual installments beginning on June 15, 2027. Following the RSU grant, he directly held 225,181 ordinary shares.
James Hardie Industries plc (symbol JHX) received a Rule 144 notice covering proposed sales of its common stock for the account of director Jesse Singh, with Goldman Sachs & Co. LLC acting as broker. The notice reports 221,457 shares of common stock, with an aggregate market value of $6,738,936.51, and 580,336,768 shares outstanding as of August 21, 2026; this is a baseline figure, not the amount being sold. Planned sales include 103,400 shares to be sold by the Jesse Singh 2024 GRAT and additional shares to be sold by the Jesse Singh 2016 Irrevocable Trust, all on the NYSE.
James Hardie Industries plc (JHX) reports outcomes from the August 20, 2026 annual general meeting and a related amendment to its Articles of Association. Shareholders approved changes to Articles 109(a) and 110 so the classified Board provisions apply consistently to all Directors, including the Chief Executive Officer, with the Board designating by majority vote the class to which any CEO-Director is assigned and the three-year re-election period running from that designation date.
Shareholders elected or re-elected Nigel Stein, Renee Peterson, and Rob Sindel as Directors for terms expiring at the 2029 annual meeting. They recommended holding advisory votes on executive compensation every year and approved the 2026 advisory “say-on-pay” resolution. On a binding basis, shareholders approved a CEO equity grant and the issue of securities under the James Hardie 2020 Non-Executive Director Equity plan, and increased the maximum aggregate annual compensation for non-executive Directors by $700,000 to $4,500,000. Shareholders also approved the financial statements and Board and EY reports for the fiscal year ended March 31, 2026, and ratified EY as external auditor for the fiscal year ending March 31, 2027, including authority for the Board to fix the auditor’s compensation.
James Hardie Industries plc (symbol JHX) has a notice of proposed sale filed under Rule 144 for shares beneficially owned by Jesse G. Singh. The filing covers a planned sale of 265,000 common shares, to be effected through stock option exercise on or about 08/21/2026, with Fidelity Brokerage Services LLC acting as broker and the shares listed on the NYSE. The transaction is indicated as a cash exercise, with the issuer identified as James Hardie Industries plc and Fidelity signing as attorney-in-fact for Jesse Singh.
James Hardie Industries plc (JHX) has agreed to sell its European fibre gypsum and cement-bonded products subsidiaries, including the Fermacell business and the fermacell® and Aestuver® brands, to Holcim for €840 million in cash, subject to customary net debt and working capital adjustments. The deal excludes the Company’s European fiber cement operations, which it intends to wind down before closing.
The transaction is expected to close in the first half of 2027, is expected to be accretive to margin profile and ROIC, and the Company plans to use approximately $600 million of proceeds to repay debt toward a net leverage target below 2.0x by September 30, 2027. The Board also authorized a new $250 million share repurchase program. The Purchase Agreement includes customary conditions, limited post-closing recourse supported by warranty and indemnity insurance, and a potential €15 million termination fee payable by the purchaser in specified circumstances.